company background image
EC8 logo

CONMED DB:EC8 Stock Report

Last Price

€70.00

Market Cap

€2.2b

7D

0%

1Y

-23.1%

Updated

27 Mar, 2024

Data

Company Financials +

EC8 Stock Overview

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide.

EC8 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health2/6
Dividends4/6

CONMED Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for CONMED
Historical stock prices
Current Share PriceUS$70.00
52 Week HighUS$125.00
52 Week LowUS$69.00
Beta1.34
1 Month Change-5.41%
3 Month Change-30.69%
1 Year Change-23.08%
3 Year Change-36.36%
5 Year Change2.71%
Change since IPO360.37%

Recent News & Updates

Recent updates

Shareholder Returns

EC8DE Medical EquipmentDE Market
7D0%-1.2%1.9%
1Y-23.1%4.3%7.3%

Return vs Industry: EC8 underperformed the German Medical Equipment industry which returned 4.3% over the past year.

Return vs Market: EC8 underperformed the German Market which returned 7.3% over the past year.

Price Volatility

Is EC8's price volatile compared to industry and market?
EC8 volatility
EC8 Average Weekly Movement5.4%
Medical Equipment Industry Average Movement5.0%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.1%
10% least volatile stocks in DE Market2.4%

Stable Share Price: EC8's share price has been volatile over the past 3 months.

Volatility Over Time: EC8's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19704,000Curt Hartmanhttps://www.conmed.com

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.

CONMED Corporation Fundamentals Summary

How do CONMED's earnings and revenue compare to its market cap?
EC8 fundamental statistics
Market cap€2.19b
Earnings (TTM)€59.57m
Revenue (TTM)€1.15b

36.8x

P/E Ratio

1.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EC8 income statement (TTM)
RevenueUS$1.24b
Cost of RevenueUS$559.90m
Gross ProfitUS$684.85m
Other ExpensesUS$620.39m
EarningsUS$64.46m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.09
Gross Margin55.02%
Net Profit Margin5.18%
Debt/Equity Ratio116.5%

How did EC8 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

38%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.